10-Q Filing

HealthLynked Corp CIK: 1680139 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001213900-21-059301`
Period End Date	20210930
Filing Date	20211115
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	f10q0921_healthlynked_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 86 Income Statement 120 Cash Flow Statement 120 Stockholders Equity 64

Balance Sheet 86 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of September 30, 2021 and December 31, 2020, respectively	`AccountsReceivableNetCurrent`	$112.98K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of September 30, 2021 and December 31, 2020, respectively	`AccountsReceivableNetCurrent`	$87.15K	USD	Point-in-time
Inventory	`InventoryNet`	$106.91K	USD	Point-in-time
Inventory	`InventoryNet`	$95.20K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$68.84K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$59.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$5.74M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$403.54K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$258.22K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $258,222 and $177,457 as of September 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	$437.29K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$177.46K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $258,222 and $177,457 as of September 30, 2021 and December 31, 2020, respectively	`PropertyPlantAndEquipmentNet`	$369.00K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $694,450 and $151,776 as of September 30, 2021 and December 31, 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.60M	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$151.78K	USD	Point-in-time
Intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$694.45K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $694,450 and $151,776 as of September 30, 2021 and December 31, 2020, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.06M	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Convertible notes payable, net of original issue discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$648.41K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$435.86K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Assets	`Assets`	$8.03M	USD	Point-in-time
Total Assets	`Assets`	$12.96M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.97M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	235.70M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	235.70M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.97M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.76M	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$89.42K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$30.54K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$150.25K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$292.84K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	$411.43K	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	-	USD	Point-in-time
Common stock issuable, par value	`CommonStockParValue`	0.00	shares	Point-in-time
Common stock issuable, par value	`CommonStockParValue`	0.00	shares	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of September 30, 2021 and December 31, 2020, respectively	`ConvertibleDebtCurrent`	$1.34M	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $-0- as of September 30, 2021 and December 31, 2020, respectively	`ConvertibleDebtCurrent`	-	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$282.21K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$701.96K	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.52M	shares	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.15M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.67M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.88M	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	$450.00K	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	$722.51K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$798.48K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$764.50K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$309.80K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$273.79K	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.19M	USD	Point-in-time
Total Liabilities	`Liabilities`	$6.68M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 235,703,829 and 187,967,881 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$23.57K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 235,703,829 and 187,967,881 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$18.80K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,517,458 and 2,150,020 shares as of September 30, 2021 and December 31, 2020, respectively	`CommonStockIssuableValue`	$728.37K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,517,458 and 2,150,020 shares as of September 30, 2021 and December 31, 2020, respectively	`CommonStockIssuableValue`	$262.27K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$22.85M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$38.50M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.48M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$351.82K	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.30M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$6.17M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$8.77M	USD	Point-in-time
Total Shareholders Equity	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$8.03M	USD	Point-in-time
Total Liabilities and Shareholders Equity	`LiabilitiesAndStockholdersEquity`	$12.96M	USD	Point-in-time

Income Statement 120 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.38M	USD	3 Qtrs
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.39M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.05M	USD	1 Quarter
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$3.50M	USD	3 Qtrs
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$767.74K	USD	1 Quarter
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$2.42M	USD	1 Quarter
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$767.74K	USD	3 Qtrs
Medicare shared savings revenue	`RevenueNotFromContractWithCustomerOther`	$2.42M	USD	3 Qtrs
Consulting and event revenue	`ConsultingAndEventRevenue`	$229.11K	USD	3 Qtrs
Consulting and event revenue	`ConsultingAndEventRevenue`	$217.60K	USD	1 Quarter
Consulting and event revenue	`ConsultingAndEventRevenue`	$69.59K	USD	1 Quarter
Consulting and event revenue	`ConsultingAndEventRevenue`	$268.02K	USD	3 Qtrs
Product revenue	`ProductRevenue`	$161.46K	USD	1 Quarter
Product revenue	`ProductRevenue`	-	USD	1 Quarter
Product revenue	`ProductRevenue`	-	USD	3 Qtrs
Product revenue	`ProductRevenue`	$512.33K	USD	3 Qtrs
Total revenue	`Revenues`	$4.04M	USD	1 Quarter
Total revenue	`Revenues`	$4.54M	USD	3 Qtrs
Total revenue	`Revenues`	$7.54M	USD	3 Qtrs
Total revenue	`Revenues`	$2.04M	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$1.91M	USD	3 Qtrs
Practice salaries and benefits	`LaborAndRelatedExpense`	$739.02K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$590.69K	USD	1 Quarter
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.31M	USD	3 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$548.67K	USD	1 Quarter
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.79M	USD	3 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.63M	USD	3 Qtrs
Other practice operating expenses	`OperatingCostsAndExpenses`	$549.09K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$1.75M	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$759.85K	USD	1 Quarter
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$824.08K	USD	3 Qtrs
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$2.16M	USD	3 Qtrs
Cost of product revenue	`CostOfRevenues`	-	USD	3 Qtrs
Cost of product revenue	`CostOfRevenues`	-	USD	1 Quarter
Cost of product revenue	`CostOfRevenues`	$474.03K	USD	3 Qtrs
Cost of product revenue	`CostOfRevenues`	$145.43K	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.66M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.12M	USD	3 Qtrs
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$1.15M	USD	1 Quarter
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$958.87K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$623.44K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$74.81K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$205.31K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.15K	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$2.88M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$4.54M	USD	1 Quarter
Total Operating Expenses and Costs	`OperatingExpenses`	$11.01M	USD	3 Qtrs
Total Operating Expenses and Costs	`OperatingExpenses`	$6.56M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-843.08K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-490.31K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.02M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-3.47M	USD	3 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-281.61K	USD	3 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-281.61K	USD	1 Quarter
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	3 Qtrs
Loss on sales of marketable securities	`MarketableSecuritiesRealizedGainLoss`	-	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	3 Qtrs
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-451.00K	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Gain (loss) on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-198.76K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-19.25K	USD	3 Qtrs
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-79.06K	USD	1 Quarter
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	-	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	3 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-65.82K	USD	1 Quarter
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-530.93K	USD	3 Qtrs
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	-	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$739.49K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$12.80K	USD	1 Quarter
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	3 Qtrs
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	-	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$687.00	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$-234.68K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$126.41K	USD	1 Quarter
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$46.00K	USD	1 Quarter
Interest income (expense)	`InterestIncomeexpense`	$13.08K	USD	3 Qtrs
Interest income (expense)	`InterestIncomeexpense`	$72.53K	USD	1 Quarter
Interest income (expense)	`InterestIncomeexpense`	$193.13K	USD	3 Qtrs
Interest income (expense)	`InterestIncomeexpense`	$4.12K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-5.22M	USD	3 Qtrs
Total other income (expenses)	`NonoperatingIncomeExpense`	$122.29K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-891.22K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-1.81M	USD	3 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-368.02K	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.73M	USD	1 Quarter
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.83M	USD	3 Qtrs
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.70M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-1.73M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-368.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.83M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.70M	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$63.86K	USD	1 Quarter
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$63.86K	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$265.18K	USD	3 Qtrs
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`DeemedDividendAmortizationOfBeneficialConversionFeature`	$88.39K	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.96M	USD	3 Qtrs
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-456.41K	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.80M	USD	1 Quarter
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.90M	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.03	USD	3 Qtrs
Basic (in Dollars per share)	`EarningsPerShareBasic`	-	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.03	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.01	USD	1 Quarter
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	3 Qtrs
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	-	USD	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	232.20M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	147.37M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	224.66M	shares	3 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	129.23M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	147.37M	shares	1 Quarter
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	224.66M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	129.23M	shares	3 Qtrs
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	232.20M	shares	1 Quarter

Cash Flow Statement 120 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.73M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-368.02K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.83M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-8.70M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$623.44K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$74.81K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$205.31K	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.15K	USD	1 Quarter
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$436.04K	USD	3 Qtrs
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$575.00K	USD	3 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$530.93K	USD	3 Qtrs
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	-	USD	3 Qtrs
Loss on sales of marketable securities	`GainLossOnInvestments`	-	USD	3 Qtrs
Loss on sales of marketable securities	`GainLossOnInvestments`	$-281.61K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$739.49K	USD	3 Qtrs
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	-	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	3 Qtrs
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-451.00K	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-4.96M	USD	3 Qtrs
Change in fair value of debt	`NoncashExpense`	$198.76K	USD	3 Qtrs
Change in fair value of debt	`NoncashExpense`	$19.25K	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$687.00	USD	3 Qtrs
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$-234.68K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$20.30K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$25.83K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$34.74K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$11.71K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-51.58K	USD	3 Qtrs
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$40.52K	USD	3 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$200.37K	USD	3 Qtrs
ROU lease assets	`IncreaseDecreaseInRightOfUseLeaseAssets`	$78.83K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$800.73K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$615.43K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$82.10K	USD	3 Qtrs
Lease liability	`IncreaseDecreaseInLeaseLiability`	$197.88K	USD	3 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	-	USD	3 Qtrs
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$46.37K	USD	3 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-52.32K	USD	3 Qtrs
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-58.89K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.63M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.09M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.74M	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$164.00K	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$322.11K	USD	3 Qtrs
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$137.39K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$13.54K	USD	3 Qtrs
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.47K	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$2.43M	USD	3 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-334.58K	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$6.95M	USD	3 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.10M	USD	3 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	-	USD	3 Qtrs
Proceeds from exercise of options and warrants	`ProceedsFromExerciseOfOptionsAndWarrants`	$350.20K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	-	USD	3 Qtrs
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.88M	USD	3 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	-	USD	3 Qtrs
Proceeds from related party loans	`ProceedsFromRelatedPartyLoans`	$149.00K	USD	3 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	3 Qtrs
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$967.76K	USD	3 Qtrs
Proceeds from government loans	`ProceedsFromGovernmentLoans`	-	USD	3 Qtrs
Proceeds from government loans	`ProceedsFromGovernmentLoans`	$1.05M	USD	3 Qtrs
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	$51.11K	USD	3 Qtrs
Repayment of vendor loans payable	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$7.25M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$271.31K	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.29M	USD	3 Qtrs
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.60M	USD	3 Qtrs
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.45M	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash, end of period	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$232.00	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$202.77K	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	3 Qtrs
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	$632.83K	USD	3 Qtrs
Forgiveness of government loans	`GainLossOnSalesOfLoansNet`	-	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$192.55K	USD	3 Qtrs
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	3 Qtrs
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$39.63K	USD	3 Qtrs
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	$126.50K	USD	Point-in-time
Incremental fair value of warrants modified to extend maturity date of convertible notes payable	`IncrementalFairValueOfWarrantsModifiedToExtendMaturityDateOfConvertibleNotesPayable`	-	USD	Point-in-time
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$4.06M	USD	3 Qtrs
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.67M	USD	3 Qtrs
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	$3.07M	USD	Point-in-time
Fair value of warrants issued in connection with conversion of convertible notes payable	`FairValueOfWarrantsIssuedInConnectionWithConversionOfConvertibleNotesPayable`	-	USD	Point-in-time
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	-	USD	3 Qtrs
Accrued liabilities relieved upon cashless exercise of warrants	`AccruedLiabilitiesRelievedUponCashlessExerciseOfWarrants`	$614.22K	USD	3 Qtrs
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	$366.30K	USD	3 Qtrs
Contingent acquisition consideration payable in common stock	`ContingentAcquisitionConsiderationPayableInCommonStock`	-	USD	3 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	3 Qtrs
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	-	USD	3 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	-	USD	3 Qtrs
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$219.74K	USD	3 Qtrs
Fair value of shares issued as initial acquisition consideration	`FairValueOfSharesIssuedAsInitialAcquisitionConsideration`	-	USD	3 Qtrs
Fair value of shares issued as initial acquisition consideration	`FairValueOfSharesIssuedAsInitialAcquisitionConsideration`	$201.68K	USD	3 Qtrs
Fair value of shares issued as contingent acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	$292.78K	USD	3 Qtrs
Fair value of shares issued as contingent acquisition consideration	`FairValueOfSharesIssuedAsAcquisitionConsideration`	-	USD	3 Qtrs
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	-	USD	3 Qtrs
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$1.06M	USD	3 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	-	USD	3 Qtrs
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$328.00K	USD	3 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	-	USD	3 Qtrs
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$135.30K	USD	3 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	3 Qtrs
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	3 Qtrs
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceived`	$3.01M	USD	3 Qtrs
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceived`	-	USD	3 Qtrs
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	$283.86K	USD	3 Qtrs
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	-	USD	3 Qtrs

Stockholders Equity 64 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$351.82K	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time
Acquisition of Cura Health Management LLC	`AcquisitionOfCuraHealthManagementLLC`	$201.68K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.61M	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.98M	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$317.16K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$348.60K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$253.78K	USD	1 Quarter
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$177.68K	USD	1 Quarter
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueAcquisitions`	$292.78K	USD	1 Quarter
Contingent acquisition consideration issuable	`StockIssuedDuringPeriodValueAcquisitions`	$366.30K	USD	1 Quarter
Sale of common and preferred stock in exchange for marketable securities	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$3.07M	USD	1 Quarter
Gain on extinguishment of related party debt allocated to additional paid in capital	`StockIssuedDuringPeriodValueOther`	$283.86K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$82.32K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$1.41M	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$33.48K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$57.44K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$690.58K	USD	1 Quarter
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$88.83K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$533.28K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$4.06M	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$652.56K	USD	1 Quarter
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$479.67K	USD	1 Quarter
Fair value of warrants issued in connection with conversion and retirement of convertible notes payable	`FairValueOfWarrantsIssuedAndModifiedInConnectionWithConversionAndRetirementOfConve`	$3.20M	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$32.43K	USD	1 Quarter
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$3.60K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$66.88K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$86.81K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$89.73K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$237.33K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$129.76K	USD	1 Quarter
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$43.70K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$63.66K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$98.50K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$39.41K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$37.41K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$38.58K	USD	1 Quarter
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$20.44K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$215.00K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$676.72K	USD	1 Quarter
Exercise of stock warrants	`Exerciseofwarrants`	$56.25K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$3.15K	USD	1 Quarter
Exercise of stock options	`ExerciseOfStockOptionsValue`	$13.30K	USD	1 Quarter
Net loss	`ProfitLoss`	$-505.76K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.52M	USD	1 Quarter
Net loss	`ProfitLoss`	$-368.02K	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.82M	USD	1 Quarter
Net loss	`ProfitLoss`	$-580.22K	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.73M	USD	1 Quarter
Balance	`StockholdersEquity`	$-2.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$351.82K	USD	Point-in-time
Balance	`StockholdersEquity`	$6.30M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.17M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$8.77M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.64M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.